Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
andMe Holding Co and Nightingale Health Plc have announced a strategic collaboration to pilot Nightingale Healths clinicallyvalidated blood metabolomics panel with a group of andMe members
Genmab AS has announced that the European Medicines Agencys Committee for Medicinal Products for Human Use has issued a positive opinion recommending conditional marketing authorization
Pfizer Inc and BioNTech SE have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended marketing authorization
Meitheal Pharmaceuticals Inc headquartered in Chicago has secured exclusive commercial rights in the US for YUSIMRY a biosimilar of Humira through a licensing and supply agreement
Genmab AS has received approval from the US Food and Drug Administration for EPKINLY to treat adults with relapsed or refractory follicular lymphoma after two or more prior systemic therapies
Simcere Zaiming an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group has announced that Enlituo an advanced antiepidermal growth factor receptor antibody drug developed in collaboration with Mabpharm Limited has recently be...
Agile Therapeutics Inc a womens healthcare company announced a definitive merger agreement with Insud Pharma SL a global pharmaceutical group based in Spain Through its US subsidiary Exeltis Project Inc Insud will acquire Agile for per share in cash...
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
